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Abstract
Diabetic ketoacidosis (DKA) is a complication that is rarely reported in patients on chronic 
dialysis. Herein, we describe the case of a patient on chronic hemodialysis who presented to 
us with acute onset diabetic ketoacidosis. A 50-year-old man with insulin-dependent diabetes 
mellitus, who was on hemodialysis for 2 years, presented to us with altered consciousness. 
Laboratory data revealed the following results: blood sugar, 110.1 mmol/L (1984 mg/dL); 
serum sodium, 107 mmol/L; β -hydroxybutyric acid, 1991 μ M; pH, 7.048. A diagnosis of 
diabetic ketoacidosis was made, and insulin therapy and hemodialysis were initiated, following 
which his parameters including blood glucose, and serum potassium and sodium improved. 
High osmotic dehydration was not observed in our patient owing to his renal dysfunction. 
The patient’s consciousness normalized following the correction of hyperglycemia and DKA. 
This case report highlights the importance of early diagnosis of DKA, and prompt initiation 
of insulin therapy and hemodialysis in patients on chronic dialysis. Therefore, in patients with 
end stage renal disease, the blood glucose correction should be followed by the restoration of 
sodium and osmolality, guided by corrected sodium concentration and effective osmolality, and 
by the appropriate adjustment of insulin and dialysis.
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Introduction
Diabetic ketoacidosis is a common medical 
emergency in patients with diabetes mellitus, 
and its appropriate diagnosis and treatment 
are important in ensuring good outcomes. 
DKA is a complication that is rarely reported 
in patients on chronic dialysis. 
DKA is considered a condition of 
hyperglycemia, hyperketonemia, and 
acidosis owing to a significant decrease 
or deficiency in insulin, or an excess of 
insulin counter-regulatory hormone. DKA 
occasionally occurs in patients with insulin-
dependent diabetes mellitus (IDDM) within 
24 hours.1 The pathophysiology of DKA is 
different in patients with preserved renal 
function compared to those with end stage 
renal disease. There is limited literature 
on this topic, with the difference being 
highlighted by just 4 case reports and two 
review articles.2-6 Herein, we describe the 
successful treatment of a patient on chronic 
hemodialysis who presented to us with DKA.
Case report
A 50-year-old man was admitted to our 
hospital with altered consciousness. He was 
diagnosed with IDDM at the age of 33 years, 
and had an episode of diabetic ketoacidosis 
at 48 years. He had been on hemodialysis for 
the last 2 years. He self-injected his insulin 
in doses of 25 units/day of human insulin 
and 10 units/day of insulin glargine. His 
glycoalbumin level (50.4%) was high, possibly 
owing to irregular eating habits and missed 
insulin doses. He had modest residual renal 
function, and was anuric.
At admission he was found to have 
the following physical findings: poorly 
responsive to pain stimulus; Glasgow coma 
scale, 8 (eye opening response, 2; best verbal 
response, 2; and best motor response, 4); 
body temperature, 36.7oC; heart rate, 55/min; 
blood pressure, 154/56 mmHg; respiratory 
rate, 13/minute without Kussmaul breathing; 
height, 161 cm; body weight, 61.3 kg (body 
weight at the end of his last dialysis, 57.6 kg; 
dry weight, 57.5 kg); mild upper and lower 
limb edema; and normal findings for head 
and neck, chest, and abdomen. He did not 
have abdominal pain, nausea, or diarrhea. His 
electrocardiogram identified sinus rhythm 
with no evidence of any segment depression. 
X-ray and computed tomography (CT) scan 
ruled out cardiomegaly (cardiothoracic 
ratio, 49%) and pneumonia. His laboratory 
findings at admission were as follows: 
significant hyperglycemia (serum glucose, 
110.1 mmol [1984 mg/dL]); acidosis (pH, 7.048; 
bicarbonate, 11.3 mmol/L); hyperketonemia 
(β-hydroxybutyric acid, 199.1 mmol/L); 
hyponatremia (serum sodium, 107 mmol/L), 
and hyperkalemia (serum potassium, 6.6 
mmol/L). There were no bacterial isolates 
found on his blood and urine cultures. Based 
on these findings, we made a diagnosis of 
DKA, with hyponatremia and hyperkalemia 
(Table 1).
The patient was placed on continuous insulin 
injection therapy, followed by hemodialysis. 
Ten units of insulin were infused 
intravenously for 2 hours, following a single 
subcutaneous injection of 5 units. Following 
insulin treatment, his blood glucose level 
dropped to 65.1 mmol/L (1172 mg/dL) prior 
to dialysis. Hemodialysis (dialysate: sodium, 
140 mmol/L; potassium, 2.0 mmol/L; glucose, 
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8.3 mmol/L; and bicarbonate, 25.0 mEq/L) 
was performed for 4 hours (membrane area, 
2.5 m2; and flow rate, 220 mL/min). At the 
end of dialysis, there was a further drop 
in blood glucose to 26.8 mmol/L (482 mg/
dL). The combination of insulin therapy and 
hemodialysis also resulted in improvement 
in serum sodium to 136 mmol/L (Figure 1). 
Similarly, his serum potassium reduced from 
6.6 mmol/L to 3.4 mmol/L. He was started 
on insulin glargine on day 4, and by day 5, 
he was restarted on subcutaneous insulin 
injections. His consciousness improved by 
the second day of his admission. There was 
no evidence of cerebral edema on CT scans 
performed on day 1 and day 3. He did not 
have any features of osmotic dehydration, 
possibly owing to his renal dysfunction. At 
the time of his discharge from hospital, his 
glycoalbumin levels decreased from 50.4% to 
30.7%.
Discussion
DKA is a metabolic disorder characterized 
by very low levels of insulin activity, leading 
to reduced glucose utilization and increased
ipolysis, finally resulting in hyperglycemia 
and free-fatty acidosis. It is known to occur 
in patients with IDDM, secondary to
discontinuation of insulin injections, infections, 
severe systemic disease, cerebrovascular 
disorders, and cardiovascular disorders. 
Although DKA is a common medical 
emergency among patients with diabetes 
mellitus, it is extremely rare in patients 
on hemodialysis. This is owing to the 
correction of acidosis, and the clearance 
of β-hydroxybutyric acid during dialysis. 
Further, the regular monitoring of blood 
Figure legend 
Figure 1. Changes in serum glucose, serum sodium, and corrected serum sodium 
levels during the treatment period. 
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Figure 1. Changes in serum glucose, serum sodium, 
and corrected serum sodium levels during the treatment 
period.
Table 1. Laboratory data at admission
Table 1. Laboratory data at admission 
WBC, white blood cells; RBC, red blood cells; Hb, hemoglobin; Hct, hematocrit; Pl, 
platelets; CRP, C-reactive protein; Glu, glucose; Na+, sodium; K+, potassium; Cl-, 
chloride; Ca2+, calcium; PO4-, phosphate; BUN, blood urea nitrogen; Cr, creatinine; 
UA, uric acid; TC, total cholesterol; TG, Triglycerides; SAP, Alkaline Phosphatase; 
GGT, γ-glutamyl transpeptidase; AST, aspartate aminotransferase; ALT, alanine 
Hematology: 
 
Blood chemistry: 
 
Ketones fraction: 
 
WBC (cells/ μL) 13900 
 
BUN (mg/dL) 56 AA (μmol/L) 830 
 
RBC (cells/ μL) 299×104 
 
Cr (mg/dL) 9.93 BHA (mmol/L) 199.1 
 
Hb (g/dL) 9.2 
 
UA (mg/dL) 6.5 TKB (μmol/L) 2821 
 
Hct (%) 28.8 
 
TC (mg/dL) 122 
  
 
Pl (cells/ μL) 16.9×104 
 
TG (mg/dL) 168 
  
Serology: 
 
SAP (IU/L) 631 Blood gas analysis: 
 
CRP (mg/dL) 0.03 
 
GGT (IU/L) 24 pH 7.048 
Blood chemistry: 
 
AST (IU/L) 19 pO2 (mmHg) 47.7 
 
Glu (mmol/L) 110.1 
 
ALT (IU/L) 11 pCO2 (mmHg) 42.1 
 
Na+ (mmol/L) 107 
 
LDH (IU/L) 336 HCO3- (mmol/L) 11.4 
 
K+ (mmol/L) 6.6 
 
CK (IU/L) 206 BE (mmol/L) -18.7 
 
Cl- (mmol/L) 78 
 
ChE (IU/L) 147 AG (mEq/L) 17.6 
 
Ca2+ (mmol/L) 8.0 
 
TP (g/dL) 6.0 
  
 
PO4- (mmol/L) 9.0 
 
Alb (g/dL) 4.0 
  
WBC, white blood cells; RBC, red blood ce ls; Hb, 
hemoglobin; H t, h matocrit; Pl, platelets; CRP, 
C-reactiv  protein; Glu, gluc se; Na+, sodium; K+, 
potassium; Cl-, chloride; Ca2+, calcium; PO4-, 
phosphate; BUN, blood ure  nitrog n; Cr, creatinine; 
UA, uric acid; TC, total cholesterol; TG, Triglycerides; 
SAP, Alkaline Phosphatase; GGT, γ -glutamyl 
transpeptidase; AST, aspartate aminotransferase; ALT, 
alanine aminotransferase; LDH, Lactate dehydrogenase; 
CK, creatine kinase; ChE, cholinesterase; TP, total 
protein; Alb, albumin; AA, acetoacetic acid; BHA, β
-hydroxybutyric acid; TKB, total ketone bodies; pO2, 
partial pressure of oxygen; pCO2, partial pressure of 
carbon dioxide; HCO3-, BE, base excess; AG, anion 
gap.
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glucose and specialist consultations during 
the dialysis sessions contribute towards 
preventing DKA. In our patient, DKA was 
induced by low compliance with diabetic 
control secondary to a general disinterest 
in life, irregular diet, and irregular insulin 
dosing, in addition to insulin deficiency. 
Clinical assessment excluded infection, 
severe systemic disease, cerebrovascular 
disorder, and cardiovascular disorder as 
contributory factors for DKA. 
Patients with preserved renal function and 
DKA present with polyuria, hyperhidrosis, 
dehydration, and weight loss secondary to 
osmotic diuresis. On the other hand, patients 
with end stage renal disease (including those 
on hemodialysis) present with oliguria or 
anuria. Further, since the renal function is 
impaired, there is an absence or reduction 
in the correction of acidosis and excretion 
of ketones, and consequently, an absence 
of dehydration. Therefore, the treatment of 
DKA in patients with renal failure should 
include blood purification therapy in addition 
to insulin injections. Immediate institution of 
insulin infusion should be the first priority, 
regardless of the status of dialysis. At a 
dose of 0.1 units/kg/h, insulin improves both 
ketonemia and hyperglycemia.7 Patients 
who are hyperglycemic prior to dialysis are 
known to demonstrate a gradual decrease 
in their blood glucose levels with the onset 
of dialysis. This is owing to glucose diffusion 
into the dialysate. We used a dialysate that 
contained sodium (140 mmol/L), potassium 
(2 mmol/L), glucose (8.3 mmol/L), and 
bicarbonate (25 mmol/L), and found that 
over the 4 hours of dialysis, the blood 
glucose and electrolyte levels approached 
the dialysate levels. There are no specific 
recommendations for initiating dialysis in 
patients with DKA and end stage renal 
disease.
In patients with DKA and end stage renal 
disease, hyponatremia and hyperosmolar 
dehydration are uncommon, as opposed 
to patients with preserved renal function. 
Patients with oliguria and anuria do not 
develop body fluid and electrolyte depletion. 
Therefore, sodium and potassium continue 
to be stored in the body, and hyperosmotic 
diuresis does not occur. In these patients, 
there is a fall of 2.4 mmol/L in serum sodium 
level for every 5.5 mmol/L (100 mg/dL) 
increase in serum glucose level. Therefore, 
corrected sodium levels are to be calculated 
as given by the following formula: measured 
serum sodium + ([Serum glucose – 100]/100) 
x 2.4).8 In our patient, although the serum 
sodium appeared to have sharply improved 
from 107 mmol/L to 136 mmol/L over 4 
hours, on applying the formula for correction, 
the sodium levels before and after 4 hours 
of treatment were 137 mmol/L and 142 
mmol/L, respectively (Figure 1). Body fluid 
correction should be based on corrected 
sodium levels in all patients, irrespective of 
the need for dialysis.9 
Effective osmolality may be calculated using 
the following equation: 
Effective osmolality (mmol/kg H2O) = 2 × 
(serum Na [mmol/L] + serum K [mmol/L]) + 
serum glucose (mg/dL)/18.8 
In our patient, the effective osmolality was 
found to be high (337.4 mmol/kg H2O). The 
osmolality decreased to 305.5 mmol/kg 
H2O over 4 hours, implying that the rate of 
reduction of effective osmolality was 4.65 
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mmol/kg/h. Current guidelines recommend a 
rate of 3 mmol/kg/h for lowering osmolality.4 
However, Gupta et al reported that mental 
obtundation did not develop when osmolality 
was rapidly decreased at a rate of 14.5 mmol/
kg/h. Rapid sodium correction is known to 
cause brain edema. However, this is not the 
case when dilutional hyponatremia results 
from an intracellular to extracellular shift 
in water, in patients on dialysis.8 Subhash 
et al described that 11 out of 12 patients 
on chronic dialysis, who presented with 
hyperglycemia and DKA, returned to normal 
consciousness following successful insulin 
therapy.10 The level of hyperglycemia as 
well as the rapidity of onset of hypertonicity 
may contribute to mental impairment.10 
Therefore, in patients with end stage renal 
disease, blood glucose correction should be 
followed by the restoration of sodium and 
osmolality. This process should be guided 
by corrected sodium concentration and 
effective osmolality, and by the appropriate 
adjustment of insulin and dialysis. 
In conclusion, hyperosmolar dehydration is 
uncommon in patients on chronic dialysis 
who develop DKA. Hyperglycemia and 
body fluid abnormalities in DKA should be 
adjusted with insulin and dialysis, based on 
corrected sodium concentration and effective 
osmolality.
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